Tech Company Financing Transactions
Magnolia Medical Technologies Funding Round
Magnolia Medical Technologies secured a $20 million Series C funding round on 1/31/2019. Backers included RTW Investments, Canepa Advanced Healthcare Fund and HealthQuest Capital.
Transaction Overview
Company Name
Announced On
1/31/2019
Transaction Type
Venture Equity
Venture Equity
Venture Equity
Amount
$20,000,000
Round
Series C
Investors
Proceeds Purpose
Magnolia Medical Technologies today announced a $20 million Series C financing round to scale the company's infrastructure and market initiatives to meet the rapidly growing demand for its Steripath® Gen2 Initial Specimen Diversion Device® (ISDD®). This funding will also advance the company's portfolio of innovative blood and bodily fluid collection and contamination prevention devices to deliver significant improvements in the accuracy, consistency and predictability of critical diagnostic laboratory tests.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
200 W. Mercer St. 500
Seattle, WA 98119
USA
Seattle, WA 98119
USA
Phone
Website
Email Address
Overview
Magnolia Medical Technologies has recently introduced the Initial Specimen Diversion Device (ISDD), a patented, Class I device registered and listed with FDA that is indicated to reduce the frequency of blood culture contamination.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 1/31/2019: Moregidge venture capital transaction
Next: 1/31/2019: Clover Health venture capital transaction
Share this article
Where The Data Comes From
We do our best to record funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs